+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Teneligliptin"

From
Metformin Market Report 2025 - Product Thumbnail Image

Metformin Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Insulin Drugs Market Report 2025 - Product Thumbnail Image

Insulin Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Teneligliptin is a drug used to treat endocrine and metabolic disorders. It is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which works by increasing the levels of incretin hormones in the body. This helps to reduce blood sugar levels in people with type 2 diabetes. Teneligliptin is also used to treat non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS). It is available in tablet form and is usually taken once daily. Teneligliptin is generally well tolerated, with the most common side effects being nausea, headache, and diarrhea. It is important to note that Teneligliptin should not be used in combination with other DPP-4 inhibitors, as this may increase the risk of hypoglycemia. Teneligliptin is marketed by several companies, including AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, and Takeda Pharmaceuticals. Show Less Read more